US Albumin Market: Growth Trends, Market Size, and Future Outlook

The US Albumin Market is experiencing steady growth due to increasing demand for albumin across pharmaceutical, biotechnology, diagnostic, and research applications. According to Market Research Future, the US albumin market was valued at approximately USD 211.31 million in 2024 and is projected to grow from USD 224.92 million in 2025 to USD 420 million by 2035, representing a CAGR of 6.44% during the forecast period.

Albumin is an important protein used in therapeutic applications, particularly in the management of conditions involving liver disease, burns, and other critical medical situations. Growing healthcare expenditure and the increasing prevalence of chronic diseases are contributing to demand for albumin-based products in the United States.

The market is segmented by application, formulation type, source, and end use. Pharmaceuticals represent a major application area, while biotechnology is emerging as an important growth segment. Injectables account for the dominant formulation type because of their widespread therapeutic use, while lyophilized formulations are gaining attention because of their stability and storage advantages.

Human Serum Albumin remains the leading source, while recombinant albumin is expected to experience strong growth because of technological advances. Hospitals represent the largest end-use segment, supported by extensive therapeutic applications.

Overall, technological innovation, increasing demand for biopharmaceutical products, advanced formulations, and expanding therapeutic applications are expected to support the continued development of the US Albumin Market.

Read More
Lukoon https://lukoon.com